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ABSTRACT
Loss of postnatal mammalian auditory hair cells (HCs) is irreversible. Earlier studies have highlighted the importance of
the Retinoblastoma family of proteins (pRBs) (i.e., Rb1, Rbl1/p107, and Rbl2/p130) in the auditory cells’ proliferation
and emphasized our lack of information on their specific roles in the auditory system. We have previously demonstrated
that lack of Rbl2/p130 moderately affects HCs’ and supporting cells’ (SCs) proliferation. Here, we present evidence
supporting multiple roles for Rbl1/p107 in the developing and mature mouse organ of Corti (OC). Like other pRBs,
Rbl1/p107 is expressed in the OC, particularly in the Hensen’s and Deiters’ cells. Moreover, Rbl1/p107 impacts maturation and postmitotic quiescence of HCs and SCs, as evidenced by enhanced numbers of these cells and the presence of
dividing cells in the postnatal Rbl1/p107−/− OC. These findings were further supported by microarray and bioinformatics
analyses, suggesting downregulation of several bHLH molecules, as well as activation of the Notch/Hes/Hey signaling
pathway in homozygous Rbl1/p107 mutant mice. Physiological assessments and detection of ectopic HC marker expression in postnatal spiral ganglion neurons (SGNs) provided evidence for incomplete cell maturation and differentiation in Rbl1/p107−/− OC. Collectively, the present study highlights an important role for Rbl1/p107 in OC cell differentiation and maturation, which is distinct from other pRBs.
Keywords: Rbl1/p107; Inner Ear; Proliferation; Differentiation; Hair Cells; Supporting Cells

1. Introduction
Differentiation of inner ear sensory hair cells (HCs) and
their associated non-sensory supporting cells (SCs) follows a unidirectional path. Early in development, organ
of Corti (OC) prosensory cells undergoes proliferation,
withdraw from the cell cycle, and commits to their specific differentiation program [1]. In mammalian vertebrates, differentiated HCs and SCs are unable to proliferate [1]. Many genes regulating cell proliferation, differentiation, and maturation elsewhere in the body are
thought to function similarly in the auditory system.
Nevertheless, the identification of specific genes participating in those processes is incomplete. There has been
growing interest in determining the role of the retinoblastoma (pRB) family, a.k.a. pocket proteins (Rb1,
Rbl1/p107, Rbl2/p130), in the inner ear [2-8]. The pRBs
Open Access

are components of a pathway that mediates a variety of
cellular responses by controlling the E2F transcription
factors (TF) and the expression of their targets during
cell cycle progression [9]. In the mouse OC, loss of Rb1
results in massive tonotopically graded proliferation of
HCs and, to some extent, SCs [2]. Rb1 deletion also
triggers the death of all sensory cells in the cochlea [2,3].
Loss of Rbl2/p130 is associated with SCs and HC proliferation in limited regions of the cochlea. Moreover, Rbl2/
p130−/− mice have a near-normal auditory sensitivity, despite the presence of supernumerary cells [8]. The clear
distinctions and similarities between Rb1 and Rbl2/p130
loss-of-function in the inner ear suggest both redundant
and non-redundant roles of the pRB family. However,
effects seen in Rb1- and Rbl2/p130-deleted OC are likely
influenced by Rbl1/p107 and vice-versa. All three pRBs
are expressed at relatively low levels in the primordial
JBBS
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OC. In the postmitotic OC, the expression of Rb1 and
Rbl2/p130 is increasingly upregulated, while Rbl1/p107
transcript levels become undetectable [8]. Whether low
Rbl1/p107 expression reflects its reduced importance in
OC cell proliferation and postmitotic quiescence, or implies a basal function not subject to differential regulation, remains to be addressed. To further address this
question and any potential relevance in HC regeneration,
we characterized the OC of Rbl1/p107−/− mice, examined
the expression profile of Rbl1/p107−/− OC by microarray,
and used bioinformatics tools to analyze the biological
relevance of Rbl1/p107 during OC development and maturation. Additionally, we assessed the physiological
phenotype of the auditory periphery of Rbl1/p107−/− mice.
Consistent with Rbl1/p107 playing a crucial role beyond
OC precursor cell cycle regulation, Rbl1/p107−/− mice
have supernumerary HCs and SCs. Moreover, Rbl1/
p107−/− mice show distinctive features of peripheral auditory immaturity, confirmed by both cytological and functional analyses. Further corroborating these observations,
more than 1000 genes changed their level of expression
in the mature Rbl1/p107−/− OC, supporting a role for
Rbl1/p107 in OC precursor cell differentiation and functional maturation.

2. Material and Methods
2.1. Animals
Rbl1/p107−/− mice were obtained from Dr. Tyler Jacks
(MIT) and crossed to C57BL/6 mice purchased from
Charles River Laboratories (Wilmington, MA). Experimental animals were genotyped by PCR following procedures described elsewhere [10]. All tissues were harvested from animals in accordance with the Creighton
University Institutional Animal Care and Use Committee
(IACUC)-approved protocol number 0853.

2.2. In Vivo Functional Assessment
Auditory evoked brainstem responses (ABRs) and distortion product otoacoustic emissions (DPOAEs) were recorded in postnatal (P) days 16 and P30 WT and Rbl1/
p107−/− animals, as previously described [8]. This study
was approved by the Boys Town National Research Hospital (BTNRH) Institutional Animal Care and Use Committee.

2.3. Semithin Sections
Inner ear tissues of P0, P16, and P35 WT and Rbl1/
p107−/− animals were prepared as previously described
[8].

2.4. Immunohistochemistry
Immunolocalization of Myosin VIIa (Proteus BiosciOpen Access
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ences), acetylated α-tubulin (Zymed), SOX2, PROX1,
and Ki-67 (Millipore) proteins was performed on formalin-fixed whole-mount preparations or paraffin-embedded 4 μm thick cross sections of dissected OC of P0, P16,
and P35 WT and Rbl1/p107−/− animals, as described elsewhere [8]. All samples were processed for antigen retrieval before the standard immunohistochemistry procedures. Microscopy and images were analyzed using a
Zeiss LMS 510 confocal microscope.

2.5. Proliferation Assay
Detection of the thymidine analog 5-ethynyl-2’-deoxyuridine (EdU) incorporation (Invitrogen/Molecular Probes)
was performed following the manufacturer’s instruction
and experimental procedures described elsewhere [8].

2.6. Apoptosis Assay
The TUNEL assay was performed as described elsewhere [11]. Apoptotic nuclei in the serial sections were
counted at 20 μm intervals to prevent double counting of
the same cell. A total of four cross sections were analyzed per genotype. Four different areas within each
cross-section were selected. All nuclei within the selected areas were counted and the ratio of TUNEL-positive nuclei to the total nuclei was calculated per section.
Student’s t-test was performed to assess statistical significance. A p-value equal to or smaller than 0.01 was
considered significant.

2.7. Western Blot
Whole otocyst/early-stage cochleae of WT and Rbl1/
p107−/− male and female mice between embryonic day
12.5 (E12.5) to E14.5 and cochleae of P0, P16, and P35
were dissected away from their attached vestibular regions and processed for Western blot analyses using primary monoclonal or polyclonal antibodies against βACTIN, Rbl1/p107, RB1 (Sigma), PROX1, SOX2,
PCNA, ID1, HES1, HES5, RBL2/p130, NOTCH1,
NOTCH1 CD (Millipore), Delta-like1 (DLL1), ID2, and
ID3 (Abcam) as previously described [8].

2.8. In Situ Hybridization (ISH)
Whole-mount ISH was performed in E12.5 whole otocyst, E18.5, and P14 cochleae as previously described [8].
Digoxigenin-labeled (DIG RNA Labeling Kit; Roche,
Indianapolis, IN) riboprobe antisense to Rbl1/p107
mRNA (478 nt) was transcribed and purified by denaturing polyacrylamide gel electrophoresis from template
DNA generated by PCR amplification of a sequenceverified clonal isolate of Rbl1/p107 derived from mouse
genomic DNA using primers (5’-CAGTTGGACATGCCTATAATTCC and 5’-TAATACGACTCACTATAGJBBS
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GGAGGAGCTAGACTGCCAAGCCAATAC). A minimum of three samples were prepared for each time
point.

2.9. Real-Time Quantitative PCR (RT-QPCR)
Total RNA isolation from whole otocyst/early stage cochleae of WT and Rbl1/p107−/− mice between E12.5 to
E14.5 and from dissected OC of P0, P14, and P35 mice.
RT-QPCR procedures using TaqMan PCR assays (Applied Biosystems; StepOne plus system) for Rb1, Rbl2/
p130, Pcna, Caspase 3, p21Cip1, p53, Atoh1, Dll1, Jag2,
Notch1, Hes1, Hes5, and Id1-3 were performed as previously described [8]. T tests were performed on the
normalized gene expression values to determine whether
differences were statistically significant. A value of p ≤
0.01 was considered significant.

2.10. Microarray Study
The Mouse Gene 1.0 ST array (Affymetrix, Inc.) was
used to look for differential expression between Rbl1/
p107−/− and WT littermates at three different time points
(E12.5, P0, and P35) in triplicate. A total of 18 arrays
were included in the analyses and 35,556 probe sets were
included on array. The experiment was designed to be in
compliance with Minimum Information about a Microarray Experiment (MIAME) standards. Each RNA
sample was processed and hybridized to individual slides.
Target preparation, including verification of RNA quality,
was assessed using a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, USA). Low-level analysis, which
converts probe-level data to gene-level expression data,
was done using RMA. RMA was implemented using the
rma function of the affy package of the Bioconductor
project in the R programming language [12]. The background correction method corrected the perfect match
(PM) probe intensities using a model based on the assumption that the observed intensities are the sum of
signal and noise. Quantile normalization was used and
the calculation of summary expression measures was
done using the median polish method, which fits a multichip linear model to the data and gives the expression
on the log2 scale [12].

2.11. Statistical Analyses of Microarray Data
Analysis of microarray data was done using BRB ArrayTools version 4.3.0 beta_3 release, developed by Dr.
Richard Simon and Amy Peng Lam (Biometrics Research Branch, National Cancer Institute:
http://linus.nci.nih.gov/ArrayTools/v4_3_0_Beta_1/Man
ual.pdf). Gene filtering was done prior to analysis, with a
gene being excluded if less than 20% of expression data
values were greater than 1.5-fold changed in either direction from the median value. Random-variance t-tests and
Open Access
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F-tests were used to determine which genes are differentially expressed between Rbl1/p107−/− and WT samples
[13]. A significance level of 0.01 was selected. Once a p
value was assigned for each gene, the pool of differentiated genes was sorted to include only those genes with
expression greater than 2-fold and smaller than 0.5. The
false discovery rate was also estimated [14]. Unsupervised hierarchical clustering of the arrays was done as
well, using both the full set and the filtered subset.
PRomoter Integration in Microarray Analysis (PRIMA)
[15] was used to search for E2f1-5 consensus-binding
sequences within the transcriptional start site of a number
of differentially regulated genes. The PRIMA analysis
used a probability weight matrix made from 1046 transcription factor binding sites (TFBS), which is the ratio
of vertebrate TFBS/mammalian TFBS × 21,973 annotated mouse genes (affy 430-2 chip).

2.12. Network Analyses
The known protein-protein interaction network (PPIN)
for Mus musculus was downloaded from the Pathway
Commons on 03/30/2012. This network contains 3143
nodes and 345,073 edges. After duplicate edges were
removed, this network contained 172,536 edges. Gene
Ontology enrichment for each network was performed
using PANTHER’s gene list analysis system [16]. The
Gene Ontology trees used were biological process, molecular function, and cellular component. Pathway biomolecule analysis and characterization was performed
using the NCI Nature's Pathway Interaction Database
[17]. Microarray expression data was taken for Rbl1/
p107 vs. WT at three time points (E12.5, P0, and P35),
creating three datasets from which to draw. Each dataset
contained differentially expressed genes, including a unique identifier, expression means, etc. Each gene also
contained a gene symbol annotation if it existed or was
known. Having known gene symbols, these genes were
filtered from each dataset. Protein-protein interaction
networks of genes listed in each dataset were created
from the M. musculus PPIN, such that, if the gene/protein
listed in the dataset was also present in the network, that
node was kept in the network. If that gene/protein was
connected to another node in the network that was also in
the dataset, the edge between the two was also kept. Each
dataset contained differentially expressed genes, including gene symbol annotation (if available), a unique
identifier, expression means, etc. Gene Symbols were
filtered from each dataset. This pre-processing step produced a set of 22 (E12.5), 148 (P0), and 680 (P35) genes.

3. Results
3.1. Rbl1/p107 Expression in the Inner Ear
Earlier assessment of pocket proteins expression in the
JBBS
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developing and postnatal OC revealed that, in comparson to the remaining pRBs, Rbl1/p107 transcript levels
are kept at consistently low levels in the auditory sensory
epithelia [8]. To detect Rbl1/p107 expression at a cellular
level, we performed whole-mount ISH in postnatal WT
mouse OC. Starting at P0, when OC cells are postmitotic,
Rbl1/p107 expression was observed in both inner hair
cell (IHC)- and outer hair cell (OHC)-associated SCs, as
well as in a subset of cells in the spiral limbus (Figures
1(A) and (B)). Although no expression was detected in
the OHCs (Figures 1(A)-(C)), some Rbl1/p107-positive
reaction was observed in the IHC nuclei, particularly in
the apical region (Figure 1(A)), as well as in Hensen’s
cells (HeC) and Deiters’ cells (DC) (Figures 1(A), (B)
and (D)). Moreover, Rbl1/p107-positive reaction was also
observed in the vestibular supporting cells (Figure 1(E)).

E12.5 E13.5 E14.5 P0 P16 P35 Liver
p 107
β-actin

Figure 1. Spatiotemporal expression of Rbl1/p107 in the WT
OC. (A), (B) In the early postmitotic OC, Rbl1/p107 transcripts were detected in the IHCs at the most apical region
of the cochlea, as well as in a subset of cells in the spiral
limbus (black arrows) and OHCs’ supporting cells throughout the length of the cochlea. Some positive reaction was
also observed in the basal region SGNs (B). (C), (D) Higher
power view of the squared region displayed in B, shown at
two different focal plans, revealed lack of positive Rbl1/p107
mRNA detection in the OHCs and IHCs (C), but not HeC
and DC (D). (E) Rbl1/p107 transcripts were also detected in
the vestibular sensory epithelia. 10 μm thick, cross sections
through the utricular epithelium revealed a subset of positive cells at the SCs’ area (inset); (F) Temporal immunoblot
analyses of Rbl1/p107 levels in cochleae of WT animals
throughout OC development and maturation. P35 WT liver
lysate was used as positive control. β-actin was used as
loading control. OHC, outer hair cells; IHC, inner hair cells;
DC, Deiters’ cells; SGN, spiral ganglion neurons; HeC,
Hensen’s cells. Scale bar: 100 μm (A, B and E), 10 μm (D, E
and inset in E).
Open Access
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Beyond P0, Rbl1/p107 expression was below in situ hybridization detection threshold (data not shown). Consistent with previous RT-QPCR temporal analyses of
Rbl1/p107 expression in the OC [8], Rbl1/p107 protein
was kept at relatively low levels throughout embryonic
and early postnatal development, becoming notably
downregulated past P0 (Figure 1(F)). Liver biopsies,
where Rbl1/p107 is known to be expressed, were collected and used as positive control tissue (Figure 1(F)).

3.2. Microarray Analyses in Rbl1/p107−/− Mice at
Different Stages of OC Development
Consistent with lack of the Rbl1/p107 gene in the Rbl1/
p107−/− OC, Rbl1/p107 mRNA expression levels in the
mutant OC exhibited a 0.00168-, 0.00171-, and 0.00164fold change at E12.5, P0, and P35, respectively. With
Rbl1/p107 expression in the mouse OC established, we
sought to understand its role during OC development and
maturation. To this end, microarray analyses were performed comparing WT and Rbl1/p107−/− dissected otocysts (E12.5) and OCs (P0 and P35). Distinct gene expression patterns at each time point were altered by
Rbl1/p107 loss, supporting the importance of Rbl1/p107
at different stages of OC development. Respectively, 84,
600, and 1005 genes were differentially expressed at
E12.5, P0, and P35 (i.e., expression levels were greater
than 2-fold or smaller than 0.5) between Rbl1/p107−/− and
WT OC at the 0.01 significance level (data not shown). To
better understand the biological significance of those
differentially expressed genes, we used Shortest-Path
network analyses [18] to detect major targets of Rbl1/
p107 within the pool of differentially expressed genes
resulting from the microarray analysis. Expression data
were taken for Rbl1/p107−/− vs. WT at E12.5, P0, and
P35, creating three datasets. The resulting networks showed
known interactions between differentially expressed
genes in the dataset, suggesting how Rbl1/p107-related
networks can work together to achieve specific functions
in the auditory sensory epithelia. Overall, genes differentially expressed between Rbl1/p107−/− and WT OC at
E12.5 involved a number of those regulating biological
processes and molecular functions, namely gene transcription and DNA binding (Table 1). Included within
those genes are a few important regulators of neurogenesis, inner ear morphogenesis, and cell fate specification
(Table 2). Shortest-Path network analyses provided evidence for protein complexes formed by the gene/protein
interactions drawn from the microarray data at E12.5
(Figures 2(A) and (A’)). Although small in origin, the
effects of Rbl1/p107 loss in the OC grew exponentially
over time to affect, directly and indirectly, a number of
major components of the neural patterning and development of the otic vesicle, such as Neurod1, Pax3, and Id3,
as highlighted by our Shortest-Path network analyses
JBBS
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Table 1. Gene Ontology (GO) of Rbl1/p107−/− mouse otocyst
and differentiated OC.
Enriched GO activity
in the network

#Mus
musculus1

#Genes2
E12.5

P0

P35

Biological Process

ET

AL.

Continued
Cell motility

454

-

-

28*

Cell adhesion

940

-

-

44*

Pattern specification process

217

-

-

17*

Segment specification

158

-

-

14*

Transcription from RNA pol.
II promoter

2101

9*

42**

133**

Natural killer cell activation

132

-

-

12*

Regulation of transcription from
RNA pol. II promoter

1588

8*

40**

107**

Immune response

562

-

-

28*

Transcription

2196

9*

42**

133**

Nervous system development

806

-

-

36*

Nucleoside, nucleotide, and
nucleic acid metabolism

3636

11*

58**

201**

Protein modification process

1253

-

-

49*

Ectoderm development

897

-

-

38*

**

313

**

**

306**

Metabolic process
Primary metabolic process
Cellular component organization

8626
8197
1056

-

87

84

**

27

70

**

**

114**

Molecular Function
DNA binding

2200

10**

44**

137**

Transcription factor
regulator activity

1934

9*

41**

107**

Nucleic acid binding

4050

11*

58**

192**

Binding

6707

-

76**

292**

Structural component of
cytoskeleton

853

-

15*

39**

Transcription cofactor activity

195

-

7*

-

Deacetylase activity

25

-

3*

25*

Chromatin binding

173

-

-

21**

Protein binding

2560

-

-

101**

DNA helicase activity

81

-

-

13**

Developmental process

2262

-

35

Cellular process

6077

-

61**

296**

Establishment and maintenance
of chromatin architecture

268

-

12**

40**

Organelle organization

298

-

12**

40**

Mesoderm development

819

-

16*

59**

Cellular component morphogenesis

763

-

15*

-

System development

1311

-

20*

80**

Intracellular signaling cascade

1083

-

16*

49*

Cell cycle

1256

-

-

110**

Immune system process

1898

-

-

111**

Protein kinase activity

554

-

-

32*

DNA metabolic process

384

-

-

43**

Kinase regulator activity

207

-

-

17*

Mitosis

392

-

-

38**

Receptor binding

884

-

-

41*

DNA replication

173

-

-

21**

Kinase activity

720

-

-

35**

Signal transduction

4013

-

-

147**

Helicase activity

155

-

-

13*

Skeletal system development

183

-

-

21**

Non-membrane spanning protein
tyrosine kinase activity

45

-

-

7*

Cell communication

4194

-

-

151**

Enzyme regulator activity

1002

-

-

42*

Apoptosis

715

-

-

43**

Cellular Component

-

**

Microtubule

242

3*

5*

39**

Intracellular

1062

-

15*

42*

DNA repair

185

-

20

**

Response to stimulus

1568

-

-

71

Chromosome segregation

125

-

-

16**

Actin cytoskeleton

388

-

6*

19*

Protein and amino acid
phosphorylation

700

-

-

39**

Extracellular matrix

434

-

-

24*

Response to stress

278

-

-

22*

Extracellular region

435

-

-

24*

Embryonic development

183

-

-

17*

Pathways

-

11

*

12

2*

4**

16

*

DNA recombination
Negative regulation of apoptosis

Open Access

77
170

-

-

Circadian Clock System
Wnt signaling pathway

346

-

**

13

346**
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Continued

Continued
**

**

Cdkn2c

1.53

Cell growth suppressor

103**

Runx2

1.66

Microtubule anchoring

7**

125*

Neurod4

1.74

Cell differentiation

7**

133*

Rbl2

2.03

Cell cycle progression/cell quiescence

-

4*

-

BMP5

2.4

Cell proliferation/stem cell marker

124

-

-

23**

Hist1h1c

2.67

Chromatin compaction

Angiogenesis

178

-

-

23**

Fgf7

4.24

Positive regulation of cell proliferation

Integrin signaling pathway

199

-

-

22**

Acta1

11.02

Actin cytoskeleton/cell growth

p53 pathway feedback loops2

50

-

-

12**

Actc1

50.47

Cell motility/apoptotic process

JAK/STAT signaling pathway

17

-

-

8**

Gsta1

0.13

Cell metabolism

PI3

112

-

-

16**

Camta1

0.15

Cell metabolism

Inflammation mediated by
chemokine and cytokine

287

-

-

23**

Gsta2

0.18

Cell metabolism

T cell activation

128

-

-

15**

Cdh18

0.18

Cell adhesion

Interleukin signaling pathway

158

-

-

16*

Mapk10

0.26

Development

PDGF signaling pathway

149

-

-

15*

Cacnb4

0.28

Metabolism/MAPK signaling pathway

B cell activation

77

-

-

10*

Kcnj10

0.28

Cell metabolism

Transcription regulation by bZIP
transcription factor

59

-

-

8*

Plcb4

0.33

Signal transduction

VEGF signaling pathway

70

-

-

8**

Fgf10

0.34

Regulation of actin cytoskeleton

Sv2c

0.36

Extracellular matrix interaction

Prox1

0.37

Development/SC marker

Calb2

0.44

Neuronal excitability/hair cell marker

Ccnd1

2.08

Cell cycle

E2f7

2.08

Cell cycle

E2f4

2.09

Cell cycle

Pole2

2.82

DNA replication

Gp9

2.91

Extracellular matrix receptor

Cebpd

2.98

Transcription

Bmp2

3.06

Development

Cdk2

3.07

Cell cycle

Runx2

3.09

Cell maturation

Ccne1

3.19

Cell cycle

Cenpn

3.19

Mitosis

Cdkn2c

3.22

Cell cycle

Hist1h1a

4.25

DNA packing

Cenpe

6.12

Transcription

E2f8

7.18

Cell cycle

19.43

Apoptosis

Apoptosis signaling pathway

136

-

8

Parkinson’s disease

103

-

7**

FGF signaling pathway

125

-

EGF receptor signaling pathway

133

Ionotropic glutamate
receptor pathway

56

p53 pathway

136

P35

1

Number of genes in the mouse genome annotated with this activity; 2Number
of genes overrepresented in the network annotated with this activity; *P <
0.01; **P < 0.00001.

Table 2. Sample of differentially expressed genes in Rbl1/
p107−/− mouse otocyst and differentiated OC.
Age

FC*‡

Example of cellular function

0.44

Inner ear morphogenesis/neurogenesis

Pax3

0.47

Inner ear morphogenesis

Cdkn1a

0.49

Cell cycle progression/cell quiescence

Gas5

0.53

Mitotic quiescence

Id3

1.39

Neurogenesis/cell fate determination

Myo9a

2.28

Signaling/epithelia cell migration

Cep350

2.47

Microtubule anchoring

Mcm5

2.55

DNA replication licensing factor

Calb2

0.3

Ca2+ binding/Neuron differentiation

Calb1

0.35

Ca2+ binding/Neuron differentiation

Pou3f4

0.4

Neurogenesis/cell fate determination

Pou4f3

0.46

Neurogenesis/cell fate determination

Gata3

0.52

Epithelial cell differentiation

Atoh1

0.53

Hair cell marker

Gene

E12.5 Neurod1

P0

Open Access

Top2a
*

‡

FC = Fold change; P < 0.001.
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Figure 2. (A) Correlation network depicting pathways directly or indirectly affected by loss of Rbl1/p107 in the
mouse sensory epithelia at E12.5. Edges represent known
protein-protein interactions between nodes. Differentially
expressed genes in the dataset showing connection to only
one other gene in the network are shown as paired nodes on
the side of the main network (A’). Of note, all affected proteins at this time point are represented on the forefront of
the network. (B)-(D) A PPIN cluster of genes directly affected by the lack of Rbl1/p107 at E12.5 (B), P0 (C), and P35
(D) is shown above. Correlations in the complete networks
generated for P0 and P35 (data not shown) were removed
for clarity. Network structures, such as high-degree nodes
(hubs), cliques, and bottlenecks were identified as having
possible critical roles in the model. High-degree nodes and
bottlenecks are known in PPINs to have a tendency to represent essential genes and clusters/cliques known to represent protein complexes or regulatory cohorts. Upregulated
(≥2-fold) and downregulated (≤0.5-fold) genes are represented by red and blue shapes, respectively. Genes represented by gray circles were found to have fold-change values smaller than 2-fold, but greater than 0.5.

(Figure 2(A)).
Next, we mined the data set to identify PPINs where
all components were differentially expressed by lack of
Rbl1/p107 (Figure 2(B)). This network summarized the
direct targets for Rbl1/p107 in the mouse otocyst at
E12.5. More specifically, lack of Rbl1/p107 was directly
associated with upregulation of genes involved in a variOpen Access
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ety of cellular processes associated with different stages
of cell division (i.e., Cdc16, Acaca, Lox, Fam83h, Cryab,
etc.) (p = 3.92E−05) and apoptosis inhibition (i.e., Rps27l
and Hspb1) (p = 1.54E−04) (Figure 2(B)). In addition to
these neurosensory-related growth factors, downregulated genes in this pathway were associated with cytoskeleton composition, organization, and intracellular vesicular trafficking (i.e., Kif5a, Kif5c, and Dnm1) (p = 2.65E−
04) (Figure 2(B)). The specific relevance of these distinct pathways to inner ear development and function, as
well as additional differentially expressed pathways observed at later time points, is yet to be determined.
Gene ontology analysis revealed that, in addition to an
overrepresentation of changed genes associated with
gene transcription, lack of Rbl1/p107 in the OC at P0
also affected the expression of a number of genes associated with nucleic acids and cell metabolism, as well as
organelle organization and intracellular signaling cascades (Table 1). While the precise pattern of expression
for a number of the differentially expressed genes is still
unknown, significantly changed genes included several
OC cell fate determination and HC differentiation markers, such as Gata3, Atoh1, and Pou4f3, which were found
to be downregulated in the absence of Rbl1/p107 (Table
2). Of note, Pou3f4, which is expressed in the spiral limbus [19], the supporting structure for the OC, was detected in our array analyses (Table 2). Such occurrence
is not completely unexpected, considering the physical
proximity between these two inner ear structures and the
inherent difficulty to manually dissect the sensory epithelia. Nevertheless, the consistent representation of bona
fide OC markers attests to the overall efficiency of our
sampling method. A variety of different pathways were
differentially affected by lack of Rbl1/p107, including
the Wnt, Fgf, and Egf signaling pathways, strongly supporting the role of Rbl1/p107 in controlling proliferation
and differentiation processes in the inner ear sensory
epithelia (Tables 2 and 3). A PPIN cluster of genes directly affected by lack of Rbl1/p107 was enriched for
genes associated with cell growth (i.e., Ddx3x, Ankrd28,
Rpsa, Lox) (p = 4.13E−04), formation of intracellular
vesicle and actin-binding proteins (Anax1 and Anax2) (p
= 2.25E−05), and apoptosis inhibition (Ankrd28 and
Peg10) (p = 1.48E−04) (Figure 2(C)). Similar to Rbl1/
p107−/− OC at E12.5, levels of the neuron-specific kinesins Kif5a and Kif5c were found to be significantly downregulated (p = 3.43E−04) at P0. Consistent with Rbl1/
p107 playing a key role in postmitotic OC homeostasis,
genes characterizing the Rbl1/p107−/− OC at P35 included
genes associated with cell cycle progression, cell proliferation, metabolism, development, and apoptosis (Table 1).
Downregulated genes at P35 included a variety of ion
channels, genes involved in cell communication and speJBBS
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Table 3. Pathway enrichment on Rbl1/p107−/− OC over time.
Pathway

Biomolecules in data set1

P-value2

Regulation of nuclear
SMAD2/3 signaling

Cdk2, Cdk4, Cdkn1a, Creb1, Ctbp1, E2f4, Ep300, Esr1, Fos, Foxo1, Hdac1, Hdac2,
Hspa8, Jun, Kat2b, Mef2c, Myc, Myod1, Ncoa1, Ncoa2, Pias4, Rbbp4, Rbbp7, Runx2,
Sap18, Sap30, Sin3a, Sin3b, Smad2, Smad4, Sp1, Tcf3, Tfdp1, Vdr

2.44E−24

Regulation of
retinoblastoma protein

Abl1, Ccna2, Ccnd1, Ccne1, Cdk2, Cdk4, Cdkn1a, Cdkn1b, Cebpd, Ctbp1, E2f1, E2f4,
Ep300, Hdac1, Id2, Id3, Jun, Mdm2, Mef2c, Myod1, Pax3, Ppp2ca, Rb1, Rb12, Rbbp4,
Runx2, Sirt1, Smarca4, Smarcb1, Spi1, Tfdp1

1.65E−21

Notch-mediated
Hes/Hey network

Cdkn1b, Ctbp1, E2f1, Ep300, Gata3, Gata1, Gata6, Hdac1, Hes6, Jak2, Kdm1a, Maml1,
Myb, Myod1, Ncoa1, Parp1, Rb1, Rbpj, Runx2, Stat3, Tcf3, Tle1

9.71E−16

PDGFR-β signaling

Abl1, Actn4, Arpc1b, Bcar1, Cbl, Cttn, Fos, Fyn, Grb2, Itgb3, Jak2, Lck, Lyn, Mllt4, Myc,
Pik3cg, Pik3r1, Plcg1, Ppp2ca, Ppp2r1a, Prkca, Prkce, Ptpn11, Src, Stat1, Stat3, Stat5a,
Stat5b, Ywhab, Ywhaq, Ywhaz

3.13E−15

Signaling events mediated by
HDAC Class I

Chd4, Ep300, Gata1, Hdac1, Hdac2, Hdac4, Hdac6, Kat2b, Nfkbia, Prkaca, Rbbp4,
Rbbp7, Rela, Sap18, Sap30, Sin3a, Sin3b, Sirt1, Stat3, Sumo1, Tnfrsf1a, Xpo1, Zfpm1

4.82E−15

Regulation of nuclear
β-catenin signaling and
target gene transcription

Ccnd1, Ctbp1, Ctnnb1, Ep300, Hdac1, Id2, Id3, Incenp, Jun, Lef1, Myc, Myog, Ncoa2,
Sall4, Skp1, Smarca4, Tcf3, Tcf4, Tcf7l1, Tcf7l2, Tle1, Xpo1, Ywhab, Ywhaq, Ywhaz

1.40E−14

FOXM1 transcription
factor network

Aurkb, Brca2, Ccna2, Ccnb1, Ccnd1, Ccne1, Cdc25b, Cdk1, Cdk2, Cdk4, Ep300, Esr1,
Fos, Hspa1a, Hspa1b, Myc, Rb1, Rbl2, Sp1

1.19E−13

E2F transcription
factor network

Brca1, Cbx5, Ccna2, Ccne1, Cdk1, Cdk2, Cdkn1a, Cdkn1b, E2f1, E2f4, Ep300, Hdac1,
Kat2b, Mybl2, Myc, Rb1, Sirt1, Smarca2, Sp1, Tfdp1, Trim28

2.69E−13

Glucocorticoid receptor
regulatory network

Cdkn1a, Creb1, Ep300, Fos, Gsk3b, Hdac1, Hdac2, Jun, Krt5, Mdm2, Ncoa1, Ncoa2,
Nfkb1, Prkaca, Rela, Smarca4, Smarcc2, Spi1, Stat1, Stat5a, Stat5b, Tp53, Tsg101

2.11E−12

Il2-mediated signaling events

Cdk2, Dok2, Fos, Fyn, Grb2, Irs1, Irs2, Jun, Lck, Myc, Pik3r1, Prkce, Ptpn11, Socs1,
Stat1, Stat3, Stat5a, Stat5b

2.66E−11

Regulation of telomerase

Abl1, Ccnd1, Cdkn1b, E2f1, Esr1, Fos, Hdac1, Hdac2, Jun, Myc, Nfkb1, Rbbp4, Rbbp7,
Sap18, Sap30, Sin3a, Sin3b, Sp1, Xrcc6

2.11E−10

C-MYB transcription
factor network

Ccnb1, Ccnd1, Cdkn1a, Cdkn1b, Cebpd, Ep300, Gata1, Hspa8, Kit, Lef1, Mad1l1,
Map3k7, Myb, Myc, Myod1, Sin3a, Smarca2, Sp1, Spi1, Trim28, Zfpm1

2.66E−10

Signaling events mediated by
stem cell factor receptor (c-Kit)

Bad, Cbl, Epor, Grap2, Grb2, Gsk3b, jak2, Kit, Lyn, Map4ki, Pik3r1, Ptpn11, Socs1,
Stat1, Stat3, Stat5a

1.82E−09

1

P value threshold = 0.001.

cialization, and genes associated with HC and SC functional maturation (Table 2). On the other hand, upregulated genes in the Rbl1/p107−/− mouse OC at this time
point consisted of a variety of genes involved in cell cycle progression, cell division, and cell death (Table 2).
As expected from the complexity of genes differentially
affected by Rbl1/p107 loss, a large and complex network
was observed at P35 (data not shown), underscoring the
variety of pathways underlying the Rbl1/p107−/− OC phenotype (Table 1). We further narrowed this network by
concentrating on clusters composed of differentially expressed genes. Similar to the previous time points, only
one cluster was revealed (Figure 2(D)). Genes directly
downregulated in the OC of P35 mice lacking Rbl1/p107
included a group associated with microtubule formation
and cytoskeleton organization (i.e., Cnp, Kif5a, Dnm1)
and synaptic plasticity (i.e., Grin1) (p = 5.10E−07).
Moreover, genes directly upregulated in the absence of
Rbl1/p107 were particularly involved with different
stages of M phase (Hspa8, Napb, Cdc45, Incenp, Kntc1,
Zwilch, Trip13, Peg10, etc.) (p = 1.31E−06) and apoptosis (Anxa1 and C3) (p = 1.27E−04).
Open Access

To address the general temporal effect of Rbl1/p107
loss, we combined the datasets from all three time points
(data not shown) and performed a pathway enrichment
analysis of the final generated network. As expected,
multiple pathways were found to be overrepresented,
most notably those associated with the regulation of the
TGF-β pathway, Notch-Hes-mediated cell differentiation,
and PDGFR-β signaling pathway, among others (Table
3).

3.3. Ectopic Cell Division and Supernumerary
Cells in the OC of Rbl1/p107−/− Mouse
Given the gene expression differences pointing to Rbl1/
p107’s role in OC cell cycle control and cell differentiation, we questioned to what extent lack of Rbl1/p107
would affect the mammalian OC. To address this question, we compared semithin sections of the developing
otocyst/early-stage inner ear of Rbl1/p107−/− and WT
mice at E12.5, E14.5, and P0. No apparent morphological differences were observed between Rbl1/p107−/− and
WT sections at either E12.5 or E14.5 (data not shown).
JBBS
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At P0, HCs and SCs along the length of the WT cochlear
duct are all postmitotic and have acquired the cell arrangement characteristic of the adult OC, with three rows
of OHCs standing on top of three rows of DCs, two rows
of pillar cells (PCs) in each side of the tunnel of Corti,
and a row of IHCs sitting on top of the inner phalangeal
and inner border cells (Figures 3(A) and (C)). In sharp contrast to WT OC, toluidine blue-stained semithin cross
sections through the apical, middle, and basal turns of the
Rbl1/p107−/− OC revealed clear signs of OC immaturity,
with disorganized cells, the presence of mitotic figures,
and enlarged nuclei, suggestive of cells in the G2 phase
of the cell cycle (Figures 3(B) and (D)). Proliferation
within the postnatal OC of Rbl1/p107−/− mouse was further analyzed by EdU incorporation at P0, P16, P21, and
P35. While no signs of proliferation were detected in the
WT OC at any of those postnatal time points (data not
shown), EdU-positive cells were detected at each of the
time points analyzed (data not shown), particularly in the
apex, where clusters of proliferating cells were still observed at postnatal time points (Figures 3(E) and (F)).
These results were corroborated by RT-QPCR (Figure
3(G)) and Western blot (Figure 3(H)) on OC cell lysates
collected at different stages of development. We specifically looked for PCNA expression, which is generally
low in quiescent cells, increasing with cell proliferation
[20]. At E12.5, PCNA protein and transcript levels were
comparable in both Rbl1/p107−/− and WT OC. By E13.5,
when the OC progenitor cells undergo their terminal mitosis, PCNA levels become elevated in Rbl1/p107−/−
compared to WT mice. Starting at E14.5, when the OC
epithelia cells either exit the cell cycle or have become
postmitotic, PCNA levels increased significantly (p <
0.01), suggesting extension of the cell cycle beyond the
normal end point. PCNA levels were still higher than
those in the WT mice later in postnatal development;
suggesting that some cells in the Rbl1/p107−/− OC may
never fully become postmitotic (Figures 3(G) and (H)).
As the unusual signs of proliferation in the posmitotic
OC could result in the generation of supernumerary HCs
and SCs, we sought to further characterize the OC morphology in Rbl1/p107−/− mice at P21 when the mouse OC
is near adult-like from a morphological and physiological
point of view [8]. Myosin VIIa (M7a) and SOX2 antibodies, which label HC and SC, respectively, were used
to identify the nature of those cells. On average, one additional row of M7a-positive cells was observed in the
apical turn of the cochleae (Figure 4(A)). Ectopic M7apositive cells were also observed along the length of the
cochleae in the OHC and IHC regions (Figures 4(E) and
(I)). Likewise, supernumerary Sox2-positive cells were
observed in the different regions of the sensory epithelia
(Figures 4(C), (G) and (K)).
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Figure 3. Rbl1/p107 deficiency affects postmitotic quiescence of the mouse OC. (A)-(D) Semithin (0.5 μm) plastic
sections of apical and basal turns of the cochlea stained with
toluidine blue show evidence of the presence of supernumerary cells in the Rbl1/p107−/− OC. The presence of dividing cells in the areas of the OC corresponding to the HeC
and DC regions (black arrows) were equally observed at
both turns of the mutant cochlea, but not in the WT control
animals. (E), (F) Whole-mount preparations of the OC of
P16 Rbl1/p107−/− and WT were assessed for cell cycle reentry using EdU (green). All tissues were counterstained with
DAPI (blue). No labeling was observed in the WT OC (data
not shown). Likewise, no signs of proliferation were observed at the OHC and IHC levels, except for a few sporadic cells infrequently observed near the IHCs (white arrow). (G), (H) PCNA transcript and protein expression
were compared between WT and Rbl1/p107−/− OC. Consistent with the presence of cycling cells in Rbl1/p107−/− OC,
PCNA levels were significantly upregulated in the postmitotic sensory epithelia (i.e., E14.5 forward). β-actin was used
as loading control. HeC, Hensen’s cells; OHC, outer hair
cells; IHC, inner hair cells; DC, Deiters’ cells; O, outer pillar cells; I, inner pillar cells; M7a, Myosin VIIa. Scale bar:
10 μm. *p < 0.01.
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3.4. Lack of Rbl1/p107 Affects Cell
Differentiation in the Mouse OC

Figure 4. Supernumerary myosin VIIa (M7a)- and Sox2positive cells in P21 p107−/− OC. (A)–(L) Additional rows of
M7a-positive cells are observed in the OHC and IHC region
of the apical turn in p107−/− (A), but not the WT (B) animals.
While the presence of additional hair cells in the apical tip
(white arrow) of the cochlea is not an uncommon trait for
WT animals, the presence of supernumerary M7a-positive
cells in the middle (Mid) (E) and basal (I) turns of Rbl1/
p107−/− cochlea (white arrows) resembles previous results
observed in p130−/− OC12. Likewise, ectopic Sox2-positive
cells were observed in Rbl1/p107−/− (C, G, K), but not in the
WT control animals (D, H, L), supporting our premises that
supernumerary cells in Rbl1/p107−/− survive to later time
points. OHC, outer hair cells; IHC, inner hair cells; DC,
Deiters’ cells. Scale bar: 10 μm.
Open Access

Of all the defects associated with Rbl1/p107 deficiency,
failed cell differentiation is among the most prominent
[21-23]. Given the previously described signs of OC
morphological immaturity, we sought to investigate the
possible impact of Rbl1/p107 loss in HC and SC differentiation. The Notch signaling pathway has been previously shown to regulate OC progenitor cell differentiation into HC and SC [24-27]. To determine whether it
was affected in Rbl1/p107−/− OC, we examined the expression of genes in the Notch-signaling pathway, including Notch1, and its ligands Jag2, Delta-like 1 (Dll1),
as well as the downstream targets Hes 1 and Hes 5 (Figures 5(A)-(E)). As revealed by RT-QPCR and supported
by Western blot analyses (Figure 5(F)), the relative expression levels of Notch1 and its downstream target Hes1
were elevated in the Rbl1/p107−/− mouse, particularly in
the postmitotic OC and at postnatal time points (Figures
5(A) and (B)). In contrast, Rbl1/p107−/− OC expression
levels for Jag2 and Dll1, were comparable between Rbl1/
p107−/− and the WT control OC during embryonic development (Figures 5(C) and (D)). However, their lower
levels in the postnatal Rbl1/p107−/− OC, supports our
previous observations of impaired cell differentiation and
OC imamturity. Except at E12.5, Hes5 relative expression levels showed no statistical differences from the WT
OC. The biological relevance of this observation remains
to be addressed.
Besides Notch-signaling, the interactive pathways for
OC precursor cell proliferation and differentiation also
require the basic helix-loop-helix (bHLH) family of TFs,
including Atoh1 and the Inhibitor of DNA binding (Id)
gene family [28-30]. During inner ear development,
members of the Id family, particularly Id1 and Id3 [29,
31], act as natural inhibitors of the Atoh1 gene, a bona
fide HC differentiation marker, and are thought to regulate HC proliferation and differentiation through their
interaction with a variety of cell cycle regulators, including the pRB family [32-35]. Previous studies showed
that Id1, Id2, and Id3 are expressed in the developing and
postnatal inner ear [29]. Moreover, Id3, which had an expression level of 1.89-fold in Rbl1/p107−/− OC at E12.5
(p = 0.0098672), was considered “borderline upregulated”
after the microarray data was sorted to include only those
genes with expression greater than 2-fold and smaller
than 0.5 (Figure 2). To further address the effects of
Rbl1/p107 deficiency in the mouse OC, we analyzed the
relative expression levels of Id1, Id2, and Id3, as well as
the bHLH Atoh1 by RT-QPCR and Western blot. In
agreement with Rbl1/p107’s role in OC cell proliferation
and differentiation, expression of the three Id genes in
the Rbl1/p107−/− OC during postmitotic development was
noticeably affected (Figures 6(A)-(D)). While Id1 and
JBBS
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Figure 5. Rbl1/p107 deficiency affects OC differentiation. (A), (B) Consistently high levels of Notch1 mRNA and its downstream target, Hes1, were observed in Rbl1/p107−/− mice, but not in the WT control mice OC. (C), (D) On the other hand,
Jag2 and Dll1 expression levels became significantly downregulated from P0 onward. (E) While at E12.5, Hes5 relative expression was lower than the control levels; no statistical differences were observed between WT and Rbl1/p107−/− Hes5 transcript levels during periods of cell proliferation and postnatal maturation. (F) Western blot analysis of protein lysates from
WT and Rbl1/p107−/− developing (E12.5 – E14.5) and developed (P0 – P35) cochleae supported the RT-QPCR results. Of note,
Rbl1/p107−/− OC had higher levels of both full-length Notch1 (~260 kD) and the activated intracellular domain of Notch1
(Notch1 CD) (160 kD). β-actin was used as loading control. *p < 0.01; **p < 0.001.
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Figure 6. Rbl1/p107 represses the Id family of proteins and favors Atoh1 expression in the mouse OC. (A)-(C) Mouse OC
lacking Rbl1/p107 displayed significantly elevated levels of Id1 (A) and Id3 (C). Id2 levels were not statistically different from
those of the WT animals (B). (D) On the other hand, levels of the bona fide HC differentiation marker, Atoh1, were significantly downregulated compared to those of the WT control animals. Western blot analyses confirmed RT-QPCR results,
supporting the importance of Rbl1/p107 in OC progenitor cell differentiation. β-actin was used as loading control. *p < 0.01;
**
p < 0.001.
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Id3 levels were upregulated in the postmitotic OC (Figures 6(A) and (C)), Id2 levels were not significantly different from those of the WT animals (Figure 6(B)). Moreover, Atoh1 transcript levels were consistently downregulated in embryonic and postnatal Rbl1/p107−/− OC
(Figure 6(D)), providing additional evidence for Rbl1/
p107’s impact on OC cell differentiation. Consistent with
the RTQPCR results, Western blot analyses confirmed
the expression pattern described for the Ids and Atoh1
transcripts (Figure 6(D)).
Because Rbl1/p107 has been shown to interact primarily with E2F TFs, we also examined mouse Notch1, Jag2,
Dll1, Hes1, Hes5, Atoh1, and Id1-3 genes for E2f1-5 consensus binding sequences. Using PRIMA [15], we searched
within 3000 bp upstream and 200 bp downstream of the
transcriptional start site of each gene listed above. PRIMA
analyses revealed the overrepresentation of a nine base
sequence, TTTGGCGCG, which is a known E2F binding
site [36], within the selected region, in all nine genes
(data not shown; p = 0.00942, Bonferroni adjusted). Therefore, in the context of the Rbl1/p107−/− murine OC, these
data suggest that Rbl1/p107 likely affects the regulation
of crucial genes associated with OC progenitor cell proliferation and differentiation, through regulation of the
E2f genes.

3.5. Lack of Rbl1/p107 Promotes Apoptosis in the
Postnatal Rbl1/p107−/− Mouse OC
Previous studies have shown that unrestricted deletion of
cell cycle-related genes leads to apoptotic death of all
sensory HCs and their associated SCs in the mouse cochlea [2-5]. To determine the impact of Rbl1/p107 deficiency on OC cell survival, cryostat sections of OC from
Rbl1/p107−/− and WT mice at P0, P16, and P35 were
examined by TUNEL assay (Figures 7(A)-(H)). In situ
end labeling of apoptotic cells by TUNEL revealed labeling in all nuclei in sections of the positive control (data
not shown). However, no apoptotic cells were observed
in the WT OC at any time point examined (data not
shown). Likewise, no signs of apoptosis were observed
in the Rbl1/p107−/− OC at P0 (data not shown). At P16 a
lower number of TUNEL-positive HCs were detected
(Figure 7(C)). By P35, apoptotic HCs and SCs were
present in higher numbers, apparently following a baseto-apex gradient of cell death (Figures 7(E) and (G)).
These results were further confirmed by the analyses of
M7a immunostained whole-mount preparations of Rbl1/
p107−/− OC at P40, showing cellular debris and signs of
cell loss throughout the length of the OC (Figures
7(I)-(K)), and particularly noticeable at the basal turn
(Figure 7(K)). Of note, M7a, a marker not normally
expressed in inner ear neurons [37], was observed in
Rbl1/p107−/− SGNs (Figure 7(I)). To further assess our
visual observation of inter-age variation in the number of
Open Access

Figure 7. Rbl1/p107 deficiency triggers postnatal apoptosis
in the mouse OC. (A), (C), (E), (G) Apoptotic cells as demonstrated by TUNEL assay were observed in Rbl1/p107−/−.
Starting with sporadic cells at P16 (white arrow) (A), staining increased significantly by P35 (black arrows) (E, G).
Cell death at later postnatal time points appeared to follow
a base-to-apex gradient. Of note, no signs of apoptotic cells
were observed in the WT control animals (B, D, F, H). (I)–
(K) Consistent with a base-to-apex pattern of HC death,
very few Myo7a-positive cells were left in the base of the
cochlea by P40 (K). Likewise, clear signs of cell loss, particularly at the OHC level, were observed over the length of
the Rbl1/p107−/− mouse OC. HeC, Hensen’s cells; OHC,
outer hair cells; IHC, inner hair cells; DC, Deiters’ cells; O,
outer pillar cells; I, inner pillar cells; SGN, spiral ganglion
neurons; M7a, Myosin VIIa. Scale bar: 10 μm.

apoptotic cells in Rbl1/p107−/− OC, we counted the number of TUNEL-positive cells per section in 10 animals at
P16 and P35. Since no apoptotic cells were observed in
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WT animals, we used only mutant animals for this analysis.
Confirming our visual observations, the mean number of
apoptotic cells per field was significantly higher at P35
compared to P16 (p < 0.01). This notion was further supported by the highly significant upregulation of Caspase
3 transcript and downregulation of p21cip1 (Cdkn1a) levels
in postnatal Rbl1/p107−/− OC (Figures 8(A) and (B)).

3.6. Rbl2/p130, but Not Rb1 Expression, Is
Upregulated in the Absence of Rbl1/p107
Cellular sensitivity to pRB deficiency seems to vary
among tissues and may reflect the ability of these genes
to functionally overlap and compensate for each other’s
loss [23,38,39]. Previously, we have shown that Rbl1/
p107 and Rb1 mRNA expression remained unchanged in
the OC of Rbl2/p130-deficient mouse [8]. To investigate
whether lack of Rbl1/p107 in the cochlea sensory epithe-
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lia can be compensated for by the remaining pRBs, we
analyzed the relative expression levels of all three pRBs
in developing and postnatal OC of Rbl1/p107−/− and WT
OC. As expected, no Rbl1/p107 mRNA or protein expression was observed in Rbl1/p107−/− mouse OC at any time
point analyzed (data not shown). However, as suggested
by our previous microarray analyses (Table 2), Rbl2/
p130 relative expression levels, which were elevated in
Rbl1/p107−/− throughout OC embryonic development, became significantly upregulated at postnatal time points
(Figure 8(C)). At P35, however, Rbl2/p130 levels were
significantly downregulated compared to the WT control
mouse (Figure 8(C)). Overall, differences in Rb1 mRNA
levels between WT and mutant OC were not found to be
statistically significant (data not shown). Combined,
these analyses suggest that Rbl1/p107 loss in the cochlear
sensory epithelia is, to some extent, compensated for by a
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Figure 8. Apoptosis and compensation in the Rbl1/p107−/− OC. (A), (B) Upregulation of the apoptotic Caspase 3 mRNA in the
postnatal OC is consistent with downregulation of the bona fide apoptotic inhibitor Cdkn1a, particularly in the late postnatal
OC. (C) While changes in Rb1 expression levels were not found to be at statistically significant levels (data not shown), Rbl2/
p130 transcript levels were found to be elevated in the postmitotic OC and significantly upregulated up to P16, when apoptotic cells were detected in the OC. At P35, when the number of apoptotic cells increased considerably, Rbl2/p130 levels were
significantly lower compared to the WT control animals. *p < 0.01; **p < 0.001.
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temporal upregulation of Rbl2/p130 transcription.

To investigate the effects of loss of the Rbl1/p107 protein
on cochlear function, ABRs and DPOAEs were examined in Rbl1/p107 null mice and compared to age-matched
controls. At P30, neural thresholds derived from ABRs
were uniformly elevated across the responsive frequency
range; however, threshold elevations were highly variable across mutant individuals (Figure 9(A)). The most
sensitive frequency region observed at P30 was a narrow
band of frequencies centered on roughly 16 kHz, with
B
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ABR thresholds ranging from approximately 35 to 70 dB
SPL in Rbl1/p107−/− mice compared to an average threshold of 26 ± 5.8 dB SPL observed for control animals.
In addition, average thresholds for the response of
Rbl1/p107−/− mice to click stimuli were elevated by approximately 31 dB relative to those of control mice. Response sensitivities for heterozygotes were indistinguishable from the WT group across the frequency range.
Threshold estimates for WT mice dropped off at an
average rate of 66 and −21 dB/octave above and below
center frequency, respectively, and threshold changes
with frequency were similar for both heterozygotes and
homozygous null mice. Closer inspection of curves re-

3.7. Absence of Rbl1/p107 Causes Hearing
Aabnormalities
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Figure 9. ABR thresholds and DPOAEs in Rbl1/p107−/− mice. (A), (C) Average ABR thresholds are shown as a function of
stimulus frequency for homozygous (Rbl1/p107−/−), heterozygous (Rbl1/p107+/−), and WT mice (Rbl1/p107+/+) at P30 (A) and
P16 (C). Thresholds of individual Rbl1/p107−/− mice are shown as dotted lines. To discern developmental trends, average
thresholds for each genetic group are replotted in (D). Average DPOAE levels are shown as a function of f2 frequency for
each genetic group at P30 in (B). Primary stimuli were varied with f2/f1 = 1.25, with f2 and f1 levels (l2 and l1, respectively)
held constant at 50 and 60 dB SPL. Error bars represent 1 standard deviation and are shown in one direction only for clarity.
Inset in (A) represents the percentage of animals at P30 in which ABRs could be elicited at the maximum output of the sound
system as a function of stimulus frequency.
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presenting individual mutant mice suggests the existence
of two populations, a high- and low-threshold group,
divided somewhat arbitrarily by the mean threshold-frequency function. Thresholds of the high-threshold group
were in the vicinity of 55 - 70 dB SPL for frequencies
centered on 16 kHz, and roll-off rates were similar to
those observed when whole population average values
were considered. Threshold estimates representing the
low-threshold group were more narrowly distributed,
ranging between 35 and 45 dB at 16 kHz, and, like the
high-threshold group, thresholds rolled off at approximately the same rate as the curve representing average
values. It is notable that none of the Rbl1/p107−/− mice
were as sensitive to tone burst stimuli as WT mice or
mice that were heterozygous for the Rbl1/p107 null allele,
regardless of frequency. Evidence that the physiological
phenotype of Rbl1/p107−/− mice is a reflection of the operational status of sensory cells, and in particular OHCs,
rather than neural components of the inner ear was
acquired by comparing DPOAEs in WT and mutant mice.
Across the responsive frequency range, average DP
levels recorded from Rbl1/p107−/− mice at P30 were consistently smaller than those measured in representatives
of WT and heterozygote cohorts (Figure 9(B)). Note that
the data shown for the Rbl1/p107−/− animals reflect the
average for the four individuals that had the lowest ABR
thresholds. No responses from the mutant animals in the
high-threshold group were obtained using the primary
stimulus conditions indicated. These data suggest that
abnormalities in the OHCs region resulting from deletion
of the Rbl1/p107 gene contribute to the functional deficits observed in neural responses in homozygous mutant animals.

3.8. Rbl1/p107 Deficiency Delays Development of
Cochlear Function
To determine whether developmental delays in cochlear
function were associated with Rbl1/p107 deficiency,
animals were studied at P16. At this age, when WT mice
are nearly mature with regard to sensitivity, the majority
of Rbl1/p107−/− mice exhibited elevated thresholds (Figure 9(C)). Thresholds in the most sensitive frequency
range of Rbl1/p107−/− mice extended from approximately
75 to 95 dB SPL with the greatest variability in thresholds observed in response to mid-range and higher stimulus frequencies. Moreover, frequency-threshold curves at P16 were relatively flat when compared to the
average curve representing homozygous Rbl1/p107−/−
animals at P30. Interestingly, two Rbl1/p107−/− mice
were as sensitive as the WT and heterozygous mice across
the frequency range studied. Furthermore, one Rbl1/
p107−/− had intermediate thresholds with peak sensitivity
of approximately 55 dB SPL at 16 kHz, and thresholdfrequency roll-off rates similar to those observed for conOpen Access
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trol animals. Differences observed in average thresholds
of Rbl1/p107−/− mice between P16 and P30 (Figure 9(D))
are consistent with the idea that loss of Rbl1/p107 results
in developmental delays in cochlear function, which is
also consistent with histologic and molecular data. Sensitivity to acoustic stimuli increased across the frequency
range for Rbl1/p107−/− mice between P16 and P30, with
the largest improvement (~20 dB) occurring in the most
sensitive frequency range. Although thresholds also improved for both heterozygous and WT mice during the
same time period, improvements were limited to a maximum of ~7 dB in response to only mid- and low-frequency stimuli (16 kHz).
One clear feature of auditory system immaturity revealed by the ABR is the duration of response peaks,
which tends to be longer in neonatal mice when compared to responses from more mature animals [40]. However, as shown in Figures 10(B) and (C) for representative
examples of ABRs acquired from Rbl1/p107−/− mice at
P16, the durations of wave I, as well as subsequent
waves, were similar to those of age-matched controls
(Figure 10(A)). This was observed for responses from
mutant mice having relatively low thresholds (Figure
10(B)), as well as from those having high thresholds
(Figure 10(C)), suggesting that elements associated with
this response feature develop normally in mutant animals.
Additional evidence that Rbl1/p107-deficient mice are
developmentally delayed comes from data indicating that
the percentage of homozygous mutant mice responsive to
the lowest stimulus frequencies studied (2.0 - 2.8 kHz),
as well as to 32 kHz, increased between P16 and P30
(Figure 9(A) inset and Figure 10(D)). At corresponding
ages, all WT animals responded to tone bursts at these
stimulus frequencies. However, even by P30, not all
Rbl1/p107−/− mice responded in the low frequency range.
Note that the number of mice responsive to the highest
frequencies declined for both Rbl1/p107−/− and WT
groups by P30, indicative of age-related hearing loss.
Although indirect, if body weight is taken as an indicator
of developmental state, the idea that development in the
Rbl1/p107−/− mouse is delayed relative to WT cohorts is
further supported by the observation that thresholds were
high in individuals with low body weights, but improved
(decreased) linearly as body weight increased in both
P16 and P30 animals (Figures 10(E) and (F)). Although
this trend was observed at both ages, the rate of improvement was greater in P16 animals than in P30 mice,
as indicated by the steeper function representing the
threshold-body weight relationship on P16.
To further pursue the question of maturity, response
latencies and amplitudes associated with ABRs from
Rbl1/p107−/− mice were considered, in the form of inputoutput (IO) curves, and compared with WT cohorts. It is
well known that prolonged response latencies and dimiJBBS
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Figure 10. Representative examples of ABR waveforms obtained in response to 16 kHz tone pips at the indicated sound pressure levels are shown for a WT mouse (A), a homozygous mutant mouse having a relatively low threshold (B), and an
Rbl1/p107−/− individual with a high threshold (C). Two overlapping replicates are shown for each stimulus level. The amplitude scale for (A)-(C) is indicated in (C). (D) The percentage of animals at P16 in which ABRs could be elicited at the maximum output of the sound system is shown as a function of stimulus frequency for both homozygous mutant and WT groups.
ABR thresholds at the most sensitive frequency were correlated with body mass for Rbl1/p107−/− mice at both P16 (E) and
P30 (F); a similar correlation was not observed for WT animals. Lines represent linear regressions fitted to the Rbl1/p107−/−
data sets. Slopes and R2 of the fitted lines are indicated in each panel. Average body masses for the WT and Rbl1/p107−/−
groups at each age studied are shown in the inset in (F). Error bars represent standard deviations.

nished response amplitudes are hallmarks of delayed de
velopment, and both conditions were observed in some,
but not all, Rbl1/p107−/− animals on P16 and P30 (Figure
11). As with sensitivity curves, a subset of IO curves
representing mutant mice closely resembled WT IO
curves, the short latency, nearly mature group, and a
second group, the prolonged latency group, that was
clearly segregated from the nearly mature group at both
ages, regardless of stimulus type. The segregation of
short and prolonged latency groups was most striking in
P16 mice under higher frequency stimulus conditions
(i.e., for responses to 22.6 and 11.3 kHz, as well as to
clicks). Essentially the same was observed when considering response amplitude IO curves in P16 mice; that is,
response amplitudes segregated into two groups; a largeamplitude, nearly mature group that extensively overlapped curves representing the WT group, and a small amplitude group representing those mice with clearly elevated thresholds. Among mutant mice at P30, segregation
into two groups was less evident, particularly when considering higher frequency conditions (11.3 and 22.6 kHz),
although separation was apparent in data representing
responses to clicks and 5.7 kHz.
To determine whether response differences reported
here are independent of one another or driven by a common immaturity, we plotted ABR wave I amplitudes
against response latencies for both P16 and P30 age
Open Access

groups (Figure 12). The degree of overlap between WT
and Rbl1/p107−/− mice in this analytical space is extensive. Large amplitude responses were associated with
relatively short latencies and low amplitudes with prolonged latencies, regardless of the genotype under consideration. This finding suggests that differences in sensitivity separating WT from Rbl1/p107−/− mice account
for most, if not the entire phenotypic variance in function
observed in this investigation.

4. Discussion
During OC development, neurosensory progenitor cells
exit the cell cycle between E13.5 and E14.5 and differentiate it [1]. This process, regulated by clonal expansion
and/or hierarchical restrictions [30], results in the loss of
multipotency. Our present data suggest that Rbl1/p107
participates in this process by negatively regulating proliferation while positively mediating differentiation,
functional maturation, and survival genes of OC prosensory progenitor cells. Rbl1/p107 was found to regulate
the number and self-renewal capacity of neural stem cells
in the brain [41,42]. In contrast, neural stem cell numbers
in embryonic Rb−/− did not differ from the WT control
animals, implying that not all pRBs affect stem cell pool
regulation [41].
Cells in postnatal Rbl1/p107−/− mice OC continue to
JBBS
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Figure 11. ABR wave I latencies (left columns) and amplitudes (right columns) are shown as a function of stimulus level for
four stimulus conditions (rows) at P16 (first and third columns) and P30 (second and fourth columns). For the WT group,
average latencies and amplitudes are shown (blue squares), along with standard deviations in each panel, and for the Rbl1/
p107−/− group, values measured from individual responses are shown in red, with different animals represented by different
symbol shapes. Averages from the P30 WT group are replotted as gray squares for the corresponding stimulus conditions in
the first and third columns to show more clearly age-related differences in the control groups.

divide past the proliferation brink, resulting in an overall
increase in the number of HeC and DCs, which are considered potential therapeutic targets for HC regeneration
[43]. As there are no definitive markers of proliferating
OC prosensory cells, we investigated the developing OC
of E12.5 Rbl1/p107−/− and WT mice by microarray
analyses. Consistent with the notion that Rbl1/p107 regulates OC precursor cell expansion, E12.5 Rbl1/p107−/−
OC showed significant upregulation of cell cycle-related
genes. In contrast, downregulated genes included several
TF, such as Neurod1, Pou4f3, and Pax3, which are expressed in committed prosensory cells and essential for
postmitotic neurosensory cell differentiation [44]. In the
embryonic OC, Rbl1/p107 may coordinate downregulation of mitotic and pro-apoptotic genes while allowing
for the expression of genes necessary for prosensory cell
Open Access

commitment and differentiation [44]. Analyses of Rbl1/
p107−/− OC at P0, showing downregulation of Gata3,
Atoh1 and Pou4f3 and the upregulation of genes associated with continued cell proliferation support our hypothesis.
The fact that HeC and DC numbers were proportionally increased compared to HCs is not surprising
since lower absolute levels of Atoh1 and Pou4f3 would
be expected to result in a relative decrease in differentiated HCs versus other cell types in the OC. This expression trend was still observed at P35, where downregulated genes included several crucial neurosensory cell
differentiation markers involved in OC maintenance and
homeostasis. Among them is the CDK inhibitor p27Kip1
(Cdkn1b), a cell cycle regulator and SC differentiation
marker [45]. Under normal circumstances, Cdkn1b exJBBS
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Figure 12. Relation between wave I latency and amplitude
measured from ABRs acquired in animals at P16 (left column) and P30 (right column) in response to the same four
stimulus conditions (rows) shown in Figure 11. Blue and red
symbols represent measurements determined from WT and
Rbl1/p107−/− animals, respectively. Values from the P30 WT
mice are replotted for the corresponding stimulus conditions as gray symbols in the left column to compare age-related differences in the control groups.

pression is inversely correlated to the proliferative status
of cells. Therefore, our findings on Cdknlb downregulation in the Rbl1/p107−/− inner ear sensory epithelia is
consistent with the observation that Rbl1/p107-deficient
OC cells are still actively cycling past the normal proliferation threshold. As expected from the unscheduled
downregulation of important homeostatic and cell survival factors, Rbl1/p107−/− OC at P35 also showed an increase in the number of upregulated apoptotic genes.
Parallel to Rbl1/p107’s importance in maintaining and
regulating neural precursor cells in the mammalian brain,
the Notch-Hes-Hey-mediated network, required for selfrenewing stem cell proliferation and stem cell mainteOpen Access
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nance [26,42,46], was significantly enriched in Rbl1/
p107−/− OC. Furthermore, postnatal Rbl1/p107−/− OC expressed elevated levels of Notch1 and Hes1 transcripts
and protein, suggesting greater activation of Notch-Hes
signaling in the postmitotic OC. The Notch signaling
pathway plays numerous roles during inner ear development [26], including the establishment of the inner ear
prosensory domains, HC and SC differentiation, and OC
patterning through “lateral inhibition” [25]. In the OC,
we hypothesize that Rbl1/p107 regulates OC progenitor
cell potency by repressing Notch1 and Hes1 expression,
but not Hes5, whose expression was unaffected in the
absence of Rbl1/p107. What supports this hypothesis is the
evidence gathered from analyses of Rbl1/p107-deficient
neural precursor cells, showing that Rbl1/p107 deficiency
in Hes1−/− mice rescues the size of the neural precursor
pool and differentiation defects [42]. Moreover, overrepresentation of potential E2F binding sites, including
those found upstream of Notch1 and Hes1, and the significant changes in the expression of these genes reinforce
our premise that Rbl1/p107 directly effects the Notch1and Hes1-mediated cell-cell signaling.
Associations of Rbl1/p107 to neurosensory cell differentiation is supported by the observation that several
key TFs, such as Prox1, Runx2, and C/ebp α, as well as
positive regulators of HC-differentiation Atoh1 and the
pRB-interacting MyoD1, were differentially affected
through Rbl1/p107 loss. As an antagonist to bHLH signaling, Id proteins, members of the HLH family, are important negative regulators of differentiation in virtually
all tissues, including the inner ear [31-33,47]. Mice
lacking both Id1 and Id3 expressed tissue-specific bHLH
factors, including Atoh1, earlier than WT control animals,
triggering premature cell cycle exit and cell differentiation [47]. In Rbl1/p107−/−, Id1 and Id3, but not Id2,
mRNAs were upregulated, particularly in the postmitotic
OC, coinciding with significant downregulation of
Atoh1.
Id2 is uniquely able to abolish the growth-suppressive
activity of the pRb family [32,48]. Certain quiescent cells
have low levels of ID2 complexed with Rbl2/p130/E2F4
and the HDAC component mSin3A, bound to the Myc
promoter [49]. The levels of Rbl2/p130, E2f4, and Myc
were significantly upregulated in Rbl1/p107−/− OC. The
increased proliferation in Rbl1/p107−/− is reflected in the
Myc increase, but just how Id2, E2f4, and Rbl2/p130
interactions influence Myc directly, or whether it reflects
the compensatory ability of the remaining pocket proteins, remains to be tested. Indeed, Rbl2/p130 upregulation in Rbl1/p107−/− OC may have, in part, compensated
for the loss of Rbl1/p107 and contributed to the functional variability observed between Rbl1/p107−/− animals.
Compared to Rbl2/p130−/− animals [8], the physiological
phenotype of Rbl1/p107−/− mice was noticeably more
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complex. In the absence of Rbl1/p107, development of
cochlear function occurs at a significantly reduced rate
relative to WT animals. The variability of response,
clearly segregated into relatively mature and definitively
immature groups, depicts functional immaturity in the
Rbl1/p107−/− cochlea. The general lack of acoustic sensitivity observed in Rbl1/p107−/− mice at P16 and the wide
range of sensitivity observed at P30, suggests that auditory function is developmentally delayed in Rbl1/p107−/−
mice. In addition, the variable expression of apoptotic
cells and possible compensatory influence of Rbl2/p130
may at least partially explain sensitivity differences observed in Rbl1/p107−/− animals, and suggests functional
overlapping between the pRBs in the auditory system.
Functional overlapping on the pRBs activity has been
documented in a variety of other systems [21,23,39],
somewhat complicating our understanding of their specific roles in critical cellular functions including cell differentiation and functional maturation.
Lack of apoptosis in Rbl1/p107−/− OC until later in
postnatal maturation suggests that the role of Rbl1/p107
in cell survival is secondary to its importance in cell cycle control and differentiation. In this sense, Rbl1/p107’s
role sharply contrasts with Rb1’s role in the OC [2-5].
Moreover, Rb1-deficient HCs are capable of retaining
function and differentiated phenotypes despite increased
proliferation [5]. Uncoupled proliferation, differentiation,
and apoptosis in Rbl1/p107-deficient OC is demonstrated
by the significant downregulation of many HC-differentiation markers and the upregulation of DNA synthesis
and proliferation markers in the embryonic and early
postnatal OC. Rb1-deficiency in the lens and CNS, as
well as HC apoptosis after Cyclin-dependent kinase inhibitors (CKIs) suppression, has been shown to involve
p53-dependent pathways [50,51]. In the CNS, Rb1-deficiency increased protein levels and DNA binding activity
of p53, resulting in upregulation of p21Cip1 (Cdkn1a).
While p53 levels were not significantly different between
the WT and Rbl1/107−/− OC (data not shown), Caspase 3
and Cdkn1a were significantly upregulated and downregulated, respectively, in the postnatal OC. Although the
mechanism underlying apoptosis in Rbl1/p107−/− OC is
yet to be resolved, upregulation of cdk2 via degradation
of Cdkn1a by Caspase 3 and upregulation of Cyclins A
and E may play a role in this process, as previously
reported [52].
In mammalian vertebrates cellular multipotency is lost
following the initial development and maturation of the
cochlear neurosensory epithelia. Our results support
Rbl1/p107 role in both the initial cell differentiation program and in establishing functional maturation of auditory sensory cells. Based upon this premise, Rbl1/p107
becomes an attractive therapeutic target for reprograming
SCs in the OC following HC loss. Just as uncommitted
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neural precursor cells in the adult brain depend on Rbl1/
p107 to retain multipotency [42], regulated Rbl1/p107
expression in the damaged cochlea is likely to initiate a
preprogramed signaling cascade leading to the generation
of new sensory HCs.
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